Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis
article
OA: closed
CC0
⤵ 33 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Daidzein-rich isoflavone aglycones were found to inhibit cell growth and inflammation in endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (45)
- Curcumin Attenuates TNF‐α‐induced Expression of Intercellular Adhesion Molecule‐1, Vascular Cell Adhesion Molecule‐1 and Proinflammatory Cytokines in Human Endometriotic Stromal Cells via openalex
- Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture via openalex
- Effect of Soy Isoflavones on Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis via openalex
- Endometriosis: Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids via openalex
- ERβ- and Prostaglandin E2-Regulated Pathways Integrate Cell Proliferation via Ras-like and Estrogen-Regulated Growth Inhibitor in Endometriosis via openalex
- Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis via openalex
- Genistein causes regression of endometriotic implants in the rat model via openalex
- G protein–coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis via openalex
- Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via openalex
- Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis via openalex
- Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis via openalex
- Parthenolide reduces cell proliferation and prostaglandin estradiol synthesis in human endometriotic stromal cells and inhibits development of endometriosis in the murine model via openalex
- Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1α Enhances Local Estrogen Biosynthesis by Stimulating Aromatase Activity in Endometriosis via openalex
- Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis1 via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Role of Estrogen Receptor-β in Endometriosis via openalex
- W2124683343 via openalex
- W2134071961 via openalex
- W2149045564 via openalex
- W2286087213 via openalex
- W2312437689 via openalex
- W2583513590 via openalex
- W6663852351 via openalex
- W6678804226 via openalex
- W1933411778 via openalex
- W1940800221 via openalex
- W1950805987 via openalex
- W1983174356 via openalex
- W1989964602 via openalex
- W2005190075 via openalex
- W2015065898 via openalex
- W2016287721 via openalex
- W2046640023 via openalex
- W2049970571 via openalex
- W2072982099 via openalex
- W2087037893 via openalex
- W2088052480 via openalex
- W2096402286 via openalex
- W2110639761 via openalex
- W2117098665 via openalex
- W2119354653 via openalex
- W2124566800 via openalex
Cited by (33)
- Targeting HSP90 as a therapeutic approach for endometriosis: insights from proteomic analysis 2026
- Molecular Interactions of Genistein as a Potential Anti-Endometriosis 2025
- Soy, estrogen, and endometriosis: bridging nutritional research with clinical practice 2025
- Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications 2025
- Soy consumption and the risk of laparoscopically confirmed endometriosis in a prospective cohort study 2025
- Phytoestrogens: A Promising Therapeutic Approach for Endometriosis Management, Insights from Preclinical and Clinical Studies 2025
- Evaluation of miR-98-5P and GAB2 gene expression in endometriosis 2024
- Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis 2023
- Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition 2023
- Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis 2023
- The influence of selected food ingredients on the reduction of the risk of endometriosis: a literature review 2022
- An Update on the Multifaceted Role of NF-kappaB in Endometriosis 2022
- Effect of Phaleria macrocarpa Extract on NF-KB, MMP-2, and MMP-9 Expression in Endometriosis Mice Model 2022
- Phytoestrogens for the Management of Endometriosis: Findings and Issues 2021
- Polyphenols as a Diet Therapy Concept for Endometriosis—Current Opinion and Future Perspectives 2021
- Endometriosis and Phytoestrogens: Friends or Foes? A Systematic Review 2021
- Peer Review #1 of "Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis (v0.1)" 2021
- Peer Review #1 of "Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis (v0.2)" 2021
- The Role of Aromatase Enzyme in Hormone Related Diseases and Plant-Based Aromatase Inhibitors as Therapeutic Regimens 2021
- Faculty Opinions recommendation of Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives. 2021
- Peer Review #2 of "Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis (v0.1)" 2021
- Peer Review #2 of "Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis (v0.2)" 2021
- Role of estrogen and estrogen-related factors in endometriosis 2021
- Kiwi Root Extract Inhibits the Development of Endometriosis in Mice by Downregulating Inflammatory Factors 2021
- Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis 2021
- Pathogenesis of Endometriosis: New Insights into Prospective Therapies 2021
- Betulinic Acid Inhibits Endometriosis Through Suppression of Estrogen Receptor β Signaling Pathway 2020
- Nutrition and Lifestyle Factors 2020
- Peroxisome proliferator-activated receptor-γ coactivator 1α-mediated pathway as a possible therapeutic target in endometriosis 2019
- In‑vitro models of human endometriosis (Review) 2019
- Natural products: Potential lead compounds for the treatment of endometriosis 2019
- Local estrogen formation and its regulation in endometriosis 2019
- Aromatase as a target for treating endometriosis 2018
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:19:49.066213+00:00
License: CC0
· commercial use OK